Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Fowler Website

Daniel H. Fowler, M.D.

Selected Publications

1)  Fisher V, Khuu H, David-Ocampo V, Byrne K, Pavletic S, Bishop M, Fowler DH, Barrett AJ, Stroncek DF.
Analysis of the recovery of cryopreserved and thawed CD34+ and CD3+ cells collected for hematopoietic transplantation.
Transfusion. 54: 1088-92, 2014.
2)  Fowler DH.
Rapamycin-resistant effector T-cell therapy.
Immunol. Rev. 257: 210-25, 2014.
3)  Elinoff JM, Bagci U, Moriyama B, Dreiling JL, Foster B, Gormley NJ, Salit RB, Cai R, Sun J, Beri A, Reda DJ, Fakhrejahani F, Battiwalla M, Baird K, Cuellar-Rodriguez JM, Kang EM, Pavletic SZ, Fowler DH, John Barrett A, Lozier JN, Kleiner DE, Mollura DJ, Childs RW, Suffredini AF.
Recombinant Human Factor VIIa for Alveolar Hemorrhage Following Allogeneic Stem Cell Transplantation.
Biol. Blood Marrow Transplant. [Epub ahead of print], 2014.
4)  Bevans MF, Mitchell SA, Barrett JA, Bishop MR, Childs R, Fowler D, Krumlauf M, Prince P, Shelburne N, Wehrlen L, Yang L.
Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors.
Biol. Blood Marrow Transplant. 20: 387-95, 2014.
5)  Bassim CW, Fassil H, Mays JW, Edwards D, Baird K, Steinberg SM, Williams KM, Cowen EW, Mitchell SA, Cole K, Taylor T, Avila D, Zhang D, Pulanic D, Grkovic L, Fowler D, Gress RE, Pavletic SZ.
Validation of the National Institutes of Health chronic GVHD Oral Mucosal Score using component-specific measures.
Bone Marrow Transplant. 49: 116-21, 2014.
6)  Castiello L, Mossoba M, Viterbo A, Sabatino M, Fellowes V, Foley JE, Winterton M, Halverson DC, Civini S, Jin P, Fowler DH, Stroncek DF.
Differential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cells.
Cytotherapy. 15: 598-609, 2013.
7)  Kochenderfer JN, Dudley ME, Carpenter RO, Kassim SH, Rose JJ, Telford WG, Hakim FT, Halverson DC, Fowler DH, Hardy NM, Mato AR, Hickstein DD, Gea-Banacloche JC, Pavletic SZ, Sportes C, Maric I, Feldman SA, Hansen BG, Wilder JS, Blacklock-Schuver B, Jena B, Bishop MR, Gress RE, Rosenberg SA.
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.
Blood. 122: 4129-39, 2013.
8)  Fowler DH.
Doubling down on PKC benefits allogeneic BMT.
Blood. 122: 2298-9, 2013.
9)  Wang JC, Felizardo TC, Au BC, Fowler DH, Dekaban GA, Medin JA.
Engineering lentiviral vectors for modulation of dendritic cell apoptotic pathways.
Virol. J. 10: 240, 2013.
10)  Felizardo TC, Foley J, Steed K, Dropulic B, Amarnath S, Medin JA, Fowler DH.
Harnessing autophagy for cell fate control gene therapy.
Autophagy. 9: 1069-79, 2013.
Click Here to View Expanded Bibliography.

This page was last updated on 4/28/2014.